The deal secures long‑term investment in a critical‑metal asset, bolstering North American nickel supply for EV batteries and preserving jobs in northern Manitoba.
The nickel market is entering a pivotal growth phase as electric‑vehicle demand accelerates, prompting miners to lock in stable supply chains. Vale’s strategic review of its Thompson operations reflects a broader industry shift toward regionalizing critical‑metal production, reducing reliance on geopolitically sensitive sources. By partnering with Canadian investors, Vale not only unlocks capital for expansion but also aligns the project with national policies aimed at securing domestic sources of battery‑grade nickel.
The consortium—Exiro Minerals, Orion Resource Partners and the Canada Growth Fund—will command 81.1% of the newly formed Exiro Nickel, injecting up to $200 million to fund mine development, exploration and infrastructure upgrades. Vale’s retained 18.9% stake ensures continuity of expertise while the off‑take agreement guarantees a market for the concentrate. This ownership structure balances private sector agility with public‑sector strategic oversight, positioning Thompson as a flagship Canadian critical‑minerals asset.
Beyond the financial mechanics, the transaction safeguards thousands of jobs in northern Manitoba and reinforces Canada’s ambition to become a global leader in clean‑energy commodities. With production already up 21% to 12,000 tonnes, the capital boost is expected to sustain higher output levels, supporting battery manufacturers and downstream processors. The deal also signals confidence in the long‑term viability of North American nickel projects, encouraging further investment across the sector.
Brazilian miner Vale announced the sale of its 18.9% stake in the Thompson nickel complex in Manitoba to a consortium of Exiro Minerals, Orion Resource Partners and the Canada Growth Fund. The investors will form a new company, Exiro Nickel, and inject up to $200 million, with the transaction expected to close by end‑2026.
Comments
Want to join the conversation?
Loading comments...